Skip to content
10-Q

Quarterly Report

NeuroOne Medical Technologies Corporation NMTC

0001213900-26-016860

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Feb 13, 2026 50.53M sh
Shares Diluted Q1 2026 · Dec 31, 2025 50.33M sh
Shares Diluted Q1 2026 · Dec 31, 2024 30.88M sh
Capex Q1 2026 · Dec 31, 2025 $40.75K
Capex Q1 2026 · Dec 31, 2024 $24.42K
Operating Cash Flow Q1 2026 · Dec 31, 2025 −$3.12M
Operating Cash Flow Q1 2026 · Dec 31, 2024 $208.05K
Cash And Equivalents Q1 2026 · Dec 31, 2025 $3.56M
Cash And Equivalents Q1 2026 · Sep 30, 2025 $6.57M
Stockholders Equity Q1 2026 · Dec 31, 2025 $6.4M
Stockholders Equity Q1 2026 · Sep 30, 2025 $7.07M
Stockholders Equity Q1 2026 · Dec 31, 2024 $2.94M
Stockholders Equity Q1 2026 · Sep 30, 2024 $822.01K
Current Liabilities Q1 2026 · Dec 31, 2025 $1.26M
Current Liabilities Q1 2026 · Sep 30, 2025 $2.3M
Total Liabilities Q1 2026 · Dec 31, 2025 $2.18M
Total Liabilities Q1 2026 · Sep 30, 2025 $3.71M
Current Assets Q1 2026 · Dec 31, 2025 $8.07M
Current Assets Q1 2026 · Sep 30, 2025 $10.23M
Total Assets Q1 2026 · Dec 31, 2025 $8.58M
Total Assets Q1 2026 · Sep 30, 2025 $10.79M
Eps Diluted Q1 2026 · Dec 31, 2025 −$0.03
Eps Diluted Q1 2026 · Dec 31, 2024 $0.06
Eps Basic Q1 2026 · Dec 31, 2025 −$0.03
Eps Basic Q1 2026 · Dec 31, 2024 $0.06
Sga Expense Q1 2026 · Dec 31, 2025 $1.89M
Sga Expense Q1 2026 · Dec 31, 2024 $2.04M
Rd Expense Q1 2026 · Dec 31, 2025 $1.39M
Rd Expense Q1 2026 · Dec 31, 2024 $1.17M
Net Income Q1 2026 · Dec 31, 2025 −$1.44M
Net Income Q1 2026 · Dec 31, 2024 $1.79M
Operating Income Q1 2026 · Dec 31, 2025 −$1.71M
Operating Income Q1 2026 · Dec 31, 2024 $1.71M
Gross Profit Q1 2026 · Dec 31, 2025 $1.57M
Gross Profit Q1 2026 · Dec 31, 2024 $1.93M
Cost Of Revenue Q1 2026 · Dec 31, 2025 $1.32M
Cost Of Revenue Q1 2026 · Dec 31, 2024 $1.35M
Revenue Q1 2026 · Dec 31, 2025 $2.89M
Revenue Q1 2026 · Dec 31, 2024 $3.27M